ERBB2 and non-small cell lung carcinoma: In this study, we analyzed a small cohort of patients from Northeast Brazil with HER2-mutant non-small cell lung cancer, conducted a comprehensive evaluation of HER2-associated alterations, and discussed the challenges in achieving accurate diagnosis.